Shock séptico. Actualización en tratamiento con suero salino hipertónico y hormona antidiurética-vasopresina

Translated title of the contribution: Septic shock. Update of treatment using hypertonic saline and antidiuretic hormone-vasopressin

Francisco Pascual-Ramirez, M. Aguirre Sánchez-Covisa, F. Araujo, S. Gil Trujillo, L. G. Collar, S. Bocharán

Research output: Contribution to journalShort survey

Abstract

Safety in the use of small volumes of hypertonic saline solution for hypovolaemic shock and in the treatment of intracranial hypertension has been demonstrated in studies in the field of resuscitation. There is little experience of this for septic shock in humans. Beneficial immunomodulatory effects have been detected in pre-clinical studies. Interactions with the pituitary-adrenal axis and with the secretion of anti-diuretic hormone are varied and suggestive, but are not sufficiently understood. On the other hand, vasopressin has cardiovascular, osmoregulatory, and coagulation effects, and also acts on the hypothalamic-pituitary-adrenal axis. There is a relative deficit of vasopressin in septic shock. Its use in these patients does seem to have any advantages as regards mortality, but may be beneficial in patients at risk from acute renal failure, or those who receive corticosteroids. Terlipressin is a vasopressin analogue that has also been studied. The synergy between vasopressin and hypertonic saline is a hypothesis that is mainly supported in pre-clinical studies. The use of hypertonic saline solution in septic shock, although promising, is still experimental, and must be restricted to the field of controlled clinical trials.

Original languageSpanish
Pages (from-to)370-378
Number of pages9
JournalRevista Espanola de Anestesiologia y Reanimacion
Volume59
Issue number7
DOIs
StatePublished - Aug 1 2012
Externally publishedYes

Fingerprint

Septic Shock
Vasopressins
Hypertonic Saline Solutions
Intracranial Hypertension
Controlled Clinical Trials
Therapeutics
Diuretics
Acute Kidney Injury
Resuscitation
Shock
Adrenal Cortex Hormones
Hormones
Safety
Mortality
Clinical Studies

Keywords

  • Fluid resuscitation
  • Hypertonic saline solution
  • Septic shock
  • Terlipressin
  • Vasopressin

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Critical Care and Intensive Care Medicine
  • Medicine(all)

Cite this

Shock séptico. Actualización en tratamiento con suero salino hipertónico y hormona antidiurética-vasopresina. / Pascual-Ramirez, Francisco; Aguirre Sánchez-Covisa, M.; Araujo, F.; Gil Trujillo, S.; Collar, L. G.; Bocharán, S.

In: Revista Espanola de Anestesiologia y Reanimacion, Vol. 59, No. 7, 01.08.2012, p. 370-378.

Research output: Contribution to journalShort survey

Pascual-Ramirez, Francisco ; Aguirre Sánchez-Covisa, M. ; Araujo, F. ; Gil Trujillo, S. ; Collar, L. G. ; Bocharán, S. / Shock séptico. Actualización en tratamiento con suero salino hipertónico y hormona antidiurética-vasopresina. In: Revista Espanola de Anestesiologia y Reanimacion. 2012 ; Vol. 59, No. 7. pp. 370-378.
@article{67994e3c78e449068d6114758d7dde10,
title = "Shock s{\'e}ptico. Actualizaci{\'o}n en tratamiento con suero salino hipert{\'o}nico y hormona antidiur{\'e}tica-vasopresina",
abstract = "Safety in the use of small volumes of hypertonic saline solution for hypovolaemic shock and in the treatment of intracranial hypertension has been demonstrated in studies in the field of resuscitation. There is little experience of this for septic shock in humans. Beneficial immunomodulatory effects have been detected in pre-clinical studies. Interactions with the pituitary-adrenal axis and with the secretion of anti-diuretic hormone are varied and suggestive, but are not sufficiently understood. On the other hand, vasopressin has cardiovascular, osmoregulatory, and coagulation effects, and also acts on the hypothalamic-pituitary-adrenal axis. There is a relative deficit of vasopressin in septic shock. Its use in these patients does seem to have any advantages as regards mortality, but may be beneficial in patients at risk from acute renal failure, or those who receive corticosteroids. Terlipressin is a vasopressin analogue that has also been studied. The synergy between vasopressin and hypertonic saline is a hypothesis that is mainly supported in pre-clinical studies. The use of hypertonic saline solution in septic shock, although promising, is still experimental, and must be restricted to the field of controlled clinical trials.",
keywords = "Fluid resuscitation, Hypertonic saline solution, Septic shock, Terlipressin, Vasopressin",
author = "Francisco Pascual-Ramirez and {Aguirre S{\'a}nchez-Covisa}, M. and F. Araujo and {Gil Trujillo}, S. and Collar, {L. G.} and S. Bochar{\'a}n",
year = "2012",
month = "8",
day = "1",
doi = "10.1016/j.redar.2012.05.037",
language = "Spanish",
volume = "59",
pages = "370--378",
journal = "Revista Espanola de Anestesiologia y Reanimacion",
issn = "0034-9356",
publisher = "Ediciones Doyma, S.L.",
number = "7",

}

TY - JOUR

T1 - Shock séptico. Actualización en tratamiento con suero salino hipertónico y hormona antidiurética-vasopresina

AU - Pascual-Ramirez, Francisco

AU - Aguirre Sánchez-Covisa, M.

AU - Araujo, F.

AU - Gil Trujillo, S.

AU - Collar, L. G.

AU - Bocharán, S.

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Safety in the use of small volumes of hypertonic saline solution for hypovolaemic shock and in the treatment of intracranial hypertension has been demonstrated in studies in the field of resuscitation. There is little experience of this for septic shock in humans. Beneficial immunomodulatory effects have been detected in pre-clinical studies. Interactions with the pituitary-adrenal axis and with the secretion of anti-diuretic hormone are varied and suggestive, but are not sufficiently understood. On the other hand, vasopressin has cardiovascular, osmoregulatory, and coagulation effects, and also acts on the hypothalamic-pituitary-adrenal axis. There is a relative deficit of vasopressin in septic shock. Its use in these patients does seem to have any advantages as regards mortality, but may be beneficial in patients at risk from acute renal failure, or those who receive corticosteroids. Terlipressin is a vasopressin analogue that has also been studied. The synergy between vasopressin and hypertonic saline is a hypothesis that is mainly supported in pre-clinical studies. The use of hypertonic saline solution in septic shock, although promising, is still experimental, and must be restricted to the field of controlled clinical trials.

AB - Safety in the use of small volumes of hypertonic saline solution for hypovolaemic shock and in the treatment of intracranial hypertension has been demonstrated in studies in the field of resuscitation. There is little experience of this for septic shock in humans. Beneficial immunomodulatory effects have been detected in pre-clinical studies. Interactions with the pituitary-adrenal axis and with the secretion of anti-diuretic hormone are varied and suggestive, but are not sufficiently understood. On the other hand, vasopressin has cardiovascular, osmoregulatory, and coagulation effects, and also acts on the hypothalamic-pituitary-adrenal axis. There is a relative deficit of vasopressin in septic shock. Its use in these patients does seem to have any advantages as regards mortality, but may be beneficial in patients at risk from acute renal failure, or those who receive corticosteroids. Terlipressin is a vasopressin analogue that has also been studied. The synergy between vasopressin and hypertonic saline is a hypothesis that is mainly supported in pre-clinical studies. The use of hypertonic saline solution in septic shock, although promising, is still experimental, and must be restricted to the field of controlled clinical trials.

KW - Fluid resuscitation

KW - Hypertonic saline solution

KW - Septic shock

KW - Terlipressin

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=84868306549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868306549&partnerID=8YFLogxK

U2 - 10.1016/j.redar.2012.05.037

DO - 10.1016/j.redar.2012.05.037

M3 - Short survey

C2 - 22770759

AN - SCOPUS:84868306549

VL - 59

SP - 370

EP - 378

JO - Revista Espanola de Anestesiologia y Reanimacion

JF - Revista Espanola de Anestesiologia y Reanimacion

SN - 0034-9356

IS - 7

ER -